Pharmacogenetics and immunosuppressive drugs in solid organ transplantation

被引：0
|
作者：
Teun van Gelder
Ron H. van Schaik
Dennis A. Hesselink
机构：
[1] Erasmus MC,Department of Hospital Pharmacy
[2] University Medical Center Rotterdam,Department of Clinical Chemistry
[3] Erasmus MC,Department of Internal Medicine
[4] University Medical Center Rotterdam,undefined
[5] Erasmus MC,undefined
[6] University Medical Center Rotterdam,undefined
来源：
Nature Reviews Nephrology | 2014年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The prediction made 15 years ago that pharmacogenetics would revolutionize pharmacotherapy has not materializedFor several immunosuppressive drugs, studies show significant associations between polymorphisms in genes encoding metabolizing enzymes and pharmacokinetic dataStudies showing a clinical benefit if immunosuppressive drug dose is based on pharmacogenetic data are lackingEfficient therapeutic drug monitoring can rapidly correct for deviations in drug exposureTreatment algorithms that include polymorphisms in genes encoding pharmacodynamic parameters, drug transporter proteins, and predictors of toxicity will provide additional benefit
引用
收藏
页码：725 / 731
页数：6
相关论文
共 50 条
  • [1] Pharmacogenetics and immunosuppressive drugs in solid organ transplantation
    van Gelder, Teun
    van Schaik, Ron H.
    Hesselink, Dennis A.
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (12) : 725 - 731
  • [2] Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation
    Szekerres, T
    Haushafer, A
    PHARMACOGENOMICS, 2005, 6 (02) : 163 - 168
  • [3] Role of pharmacogenetics of immunosuppressive drugs in organ transplantation
    Thervet, Eric
    Anglicheau, Dany
    Legendre, Christophe
    Beaune, Philippe
    THERAPEUTIC DRUG MONITORING, 2008, 30 (02) : 143 - 150
  • [4] Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs
    Kurzawski, Mateusz
    Drozdzik, Marek
    PHARMACOGENOMICS, 2013, 14 (09) : 1099 - 1118
  • [5] Immunosuppressive drugs after solid organ transplantation
    van Sandwijk, M. S.
    Bemelman, F. J.
    ten Berge, I. J. M.
    NETHERLANDS JOURNAL OF MEDICINE, 2013, 71 (06): : 281 - 289
  • [6] Basic immunosuppressive drugs outside solid organ transplantation
    Braun, F
    Behrendt, M
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (03) : 267 - 291
  • [7] New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs
    Pouche, Lucie
    Stojanova, Jana
    Marquet, Pierre
    Picard, Nicolas
    PHARMACOGENOMICS, 2016, 17 (03) : 277 - 296
  • [8] THE INFLUENCE OF IMMUNOSUPPRESSIVE DRUGS ON THE EPITHELIAL MICROENVIRONMENT IN SOLID ORGAN TRANSPLANTATION
    Akhdar, A.
    Mueller, B.
    Neudoerfl, C.
    Stevanovic-Meyer, M.
    Keil, J.
    Falk, C.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 23 - 23
  • [9] The Influence of Immunosuppressive Drugs On the Epithelial Microenvironment in Solid Organ Transplantation.
    Falk, C.
    Akhdar, A.
    Keil, J.
    Stevanovic-Meyer, M.
    Neudoerfl, C.
    Mueller, B.
    TRANSPLANTATION, 2014, 98 : 279 - 280
  • [10] The Influence of Immunosuppressive Drugs On the Epithelial Microenvironment in Solid Organ Transplantation.
    Falk, C.
    Akhdar, A.
    Keil, J.
    Stevanovic-Meyer, M.
    Neudoerfl, C.
    Mueller, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 279 - 280
12345